Accelerated extracellular matrix turnover during exacerbations of COPD.
about
Challenges and Current Efforts in the Development of Biomarkers for Chronic Inflammatory and Remodeling Conditions of the LungsThe extracellular matrix - the under-recognized element in lung disease?High levels of biomarkers of collagen remodeling are associated with increased mortality in COPD - results from the ECLIPSE study.Biomarkers of extracellular matrix turnover are associated with emphysema and eosinophilic-bronchitis in COPD.Protein degradation fragments as diagnostic and prognostic biomarkers of connective tissue diseases: understanding the extracellular matrix message and implication for current and future serological biomarkers.The minor collagens in articular cartilage.Genome-wide association analyses for lung function and chronic obstructive pulmonary disease identify new loci and potential druggable targets.The G allele of MMP12 -82 A > G promoter polymorphism as a protective factor for COPD in Bulgarian population.Altered collagen turnover in factor VIII-deficient rats with hemophilic arthropathy identifies potential novel serological biomarkers in hemophilia.Biomarkers of collagen turnover are related to annual change in FEV1 in patients with chronic obstructive pulmonary disease within the ECLIPSE study.Age-related collagen turnover of the interstitial matrix and basement membrane: Implications of age- and sex-dependent remodeling of the extracellular matrix.A Serological Biomarker of Versican Degradation is Associated with Mortality Following Acute Exacerbations of Idiopathic Interstitial Pneumonia.IFNΛ3/4 locus polymorphisms and IFNΛ3 circulating levels are associated with COPD severity and outcomes.Proteinase 3; a potential target in chronic obstructive pulmonary disease and other chronic inflammatory diseases
P2860
Q26766294-70057FD3-9DFF-4553-A99A-FAA9862026B0Q28075842-DFE19625-890A-4166-ADF8-79313CE84CAAQ37311290-98E89BAD-F794-4E03-915B-E1EAF483A37BQ37595806-5DA8EB63-39F4-4335-AC0E-14347F6BC47DQ38675211-61A2D5AB-252E-4797-A05C-A241DCEECD3FQ39141588-73647F21-F5C5-4755-89BD-6E65938DD4C7Q39568339-80DC996C-7C3A-42D6-ABF8-8161D709A3CDQ43926090-5E054AE4-EF5C-419B-91F1-735B35D73C07Q45858678-A74DD0C0-002E-48F8-85E2-24724878AF56Q47112547-7C3304A0-0240-4032-9D55-F593C3B63375Q52806365-4FC7D81A-5978-40B9-9635-13171E9BCDE0Q55262276-8AD7FC15-6B5B-40A0-9B4F-7C6694D522A0Q55506706-F137E239-C1A8-4D59-B76F-CD0CC1A46D4CQ58711278-B952A44F-3F70-4853-872C-07472F2B6E68
P2860
Accelerated extracellular matrix turnover during exacerbations of COPD.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Accelerated extracellular matrix turnover during exacerbations of COPD.
@ast
Accelerated extracellular matrix turnover during exacerbations of COPD.
@en
type
label
Accelerated extracellular matrix turnover during exacerbations of COPD.
@ast
Accelerated extracellular matrix turnover during exacerbations of COPD.
@en
prefLabel
Accelerated extracellular matrix turnover during exacerbations of COPD.
@ast
Accelerated extracellular matrix turnover during exacerbations of COPD.
@en
P2093
P2860
P50
P1433
P1476
Accelerated extracellular matrix turnover during exacerbations of COPD
@en
P2093
Diana J Leeming
Morten A Karsdal
Peter Lange
P2860
P2888
P356
10.1186/S12931-015-0225-3
P577
2015-06-11T00:00:00Z
P5875
P6179
1002472442